HCW Biologics (HCWB) EBITDA Margin (2022 - 2025)
HCW Biologics (HCWB) reported EBITDA Margin of -15938.10% for Q4 2025, down 15313.75 percentage points from -624.36% a year earlier but up 4042.81 percentage points from the prior quarter.
HCW Biologics (HCWB) EBITDA Margin (2022 - 2025) Analysis & Trends
For FY2025, HCW Biologics posted EBITDA Margin of -22349.79%, down 21248.33 percentage points from FY2024.
- EBITDA Margin has declined for three consecutive years, with a five-year change of -22221.69 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at -1101.46% in FY2024 (-236.44 pp), -865.02% in FY2023 (-651.38 pp) and -213.64% in FY2022.
- Five-year quarterly EBITDA Margin spans a low of -48429.94% in Q2 2025 and a high of -55.75% in Q1 2022.
- Year over year, EBITDA Margin has now declined in each of the last four quarters, with an average year-over-year change of -12596.07 percentage points over the last eight quarters.
- The high point for year-over-year EBITDA Margin in five years was Q1 2024 (a gain of 11441.91 percentage points); the low point was Q2 2025 (a drop of 46005.12 percentage points).
- Per Business Quant data, the three quarters before Q4 2025 came in at -19980.91% (Q3 2025), -48429.94% (Q2 2025) and -30538.84% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | HCW Biologics | 2.27 Mn | -3.96 Mn | -93,887.00 | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -15,938.10% |
| Sep 30, 2025 | -19,980.91% |
| Jun 30, 2025 | -48,429.94% |
| Mar 31, 2025 | -30,538.84% |
| Dec 31, 2024 | -624.36% |
| Sep 30, 2024 | -833.94% |
| Jun 30, 2024 | -2,424.82% |
| Mar 31, 2024 | -643.48% |
| Dec 31, 2023 | -792.57% |
| Sep 30, 2023 | -562.70% |
| Jun 30, 2023 | -678.57% |
| Mar 31, 2023 | -12,085.39% |
| Dec 31, 2022 | -402.98% |
| Sep 30, 2022 | -213.12% |
| Jun 30, 2022 | -740.42% |
| Mar 31, 2022 | -55.75% |
HCW Biologics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HCWB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "HCWB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=HCWB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();